Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

European Research Council grant · Running

DiffusOMICS A new technology to probe molecular interaction in cells at high throughput

Coordinator
Kungliga Tekniska Hoegskolan, Sweden
Runs
1 April 2024 to 30 September 2025
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101158292

What the project is doing

In the project's own words, from its summary on CORDIS.

Protein oligomers and aggregates are pillars of many cellular processes and can be associated with a number of life-threatening neurodegenerative diseases. These processes are often context-dependent but are hard to detect in situ with available technologies. The ideal instrument can target specific proteins of medical interest in their physiological contexts, resolve nano-distances (1-100 nm) and capture dynamics of association and dissociation (ns-ms).

The DiffusOMICS project aims to fill this methodological gap by prototyping a high-throughput fluorescence-based approach able to measure the rotational diffusion properties of molecules in vivo and in situ. The concept is based on our recent publication, where we utilize intelligent fluorescent probes together with polarized light to investigate the rotational dynamics of large molecular complexes. Rotational diffusion is highly sensitive to change in mass making the technique ideal to detect the presence of aggregates and report on molecular size and local viscosity.

Due to the nature of the signal, the measurements can be done in cells and tissues at high throughput, making the technology appealing for industrial screening applications. The goal of the project is to establish both the technological foundation and the collaborations needed to develop a prototype instrument and to record the very first high-throughput molecular interaction maps in neurons. DiffusOMICS possesses all the essential qualities to become a game-changing technology for drug screening due to its sensitivity, specificity and speed, making it suitable for automated recordings.

DiffusOMICS maps will carry information on the whole population of aggregates localized in different neuronal compartments and can track changes in aggregation responses to drug perturbations and mutagenesis in neuronal proteins. The outcome will be key to engage industrial strategic partners and it paves the way for a new paradigm of drug screening in situ.

Topics

Who is involved

OrganisationCityCountryRole
Kungliga Tekniska HoegskolanStockholmSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI